Loading...
NPI 1548399561 · Saint Louis, MO · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Des Peres Eye Surgery Center, LLC is a ambulatory surgical clinic/center provider located in Saint Louis, Missouri. This profile covers 22 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Des Peres Eye Surgery Center, LLC |
| Address | 12990 Manchester Rd |
| City | Saint Louis |
| State | MO |
| ZIP | 63131 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | March 5, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3.5M |
| Medicaid | $162.2K |
DES PERES EYE SURGERY CENTER, LLC is an ambulatory surgical center with a long NPI tenure (enumerated ~19 years ago), indicating established operations and continuity in the market since 2007-03-05. The code mix is dominated by ophthalmic surgical procedures and intraoperative ophthalmic pharmacologics, consistent with an eye-focused ASC rather than a general surgical facility.
Medicare revenue totals $3.5M while Medicaid revenue is $162.2K, indicating Medicare is by far the dominant payer for this facility; the provider functions effectively as a Medicare-focused surgical center with limited Medicaid volume on file. The Medicaid footprint is small in absolute dollars relative to Medicare, so payer-mix risk is concentrated toward Medicare reimbursement trends.
Revenue concentration on Medicare is high: the precomputed top 3 Medicare codes by revenue account for 67.8% of the provider’s total Medicare revenue, showing dependence on a narrow set of high-value ophthalmic procedures. For Medicaid, the top 3 codes account for 100.0% of Medicaid revenue, indicating Medicaid billing is nearly entirely captured by a handful of codes and is extremely concentrated.
The single largest Medicare code is 66984 (cataract extraction with intraocular lens insertion), which generated $1.8M and represents 49.6% of this provider’s Medicare revenue; the provider ranks #902 of 15965 nationally (94th percentile), signaling an above-typical national volume for cataract surgery and a strong surgical volume in this core service line. The Medicaid side is also heavily concentrated in 66984 with 1.2K claims and $159.7K making up 98.3% of Medicaid revenue, where the provider ranks #2 of 61 in-state (98th percentile) and is an extreme state-level outlier for cataract procedures under Medicaid.
Several other Medicare codes show specialty surgical activity and above-typical national volumes: 66991 (insertion of IOL with aqueous drainage device) contributed $290.4K (8.1% of Medicare revenue) and ranks in the 97th percentile nationally, while vitrectomy-related codes such as 67042 and 67036 also appear in the top contributors and rank in the 91st–97th percentiles. These patterns point to a capacity for complex anterior and posterior segment surgery beyond routine cataract cases.
The facility bills substantial quantities of ophthalmic pharmaceutical supply codes: J1097 (phenylephrine/ketorolac irrigant) produced $360.4K (10.1% of Medicare revenue) and ranks #53 of 443 nationally (88th percentile), and J2403 and J1096 together contribute meaningful Medicare revenue. This indicates integrated intraoperative medication use and suggests that supply/medication billing is a nontrivial part of the ASC’s revenue mix.
Competitive standing varies by code: for flagship procedures like 66984 and 66991 the provider ranks in very high national percentiles (94th and 97th respectively), positioning it as a major national-volume provider for those codes. In contrast, several lower-revenue Medicare codes rank much lower nationally or in the middle percentiles, reflecting that dominance is concentrated in a few ophthalmic procedure lines rather than across all ophthalmic services.
Medicaid-specific rankings underscore state-level dominance for cataract surgery: 66984 ranks #2 of 61 in-state (98th percentile) and is labeled an extreme outlier, confirming the center’s outsized role in delivering Medicaid-covered cataract operations in Missouri. Other Medicaid codes are negligible in revenue and either have no meaningful peer comparison or reflect administrative reporting items with $0 paid, reinforcing the conclusion that Medicaid billing activity is narrowly focused and limited in scale.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
22 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 2,150 | $820 | $1.8M |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 4,680 | $80 | $360.4K |
| 66991 | The provider inserts an intraocular lens prosthesis during the same session as extracapsular cataract extraction. The provider also inserts one or more anterior segment aqueous drainage devices in… | 120 | $2,440 | $290.4K |
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 183,200 | $1 | $183.2K |
| 67042 | In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina… | 90 | $1,480 | $136.3K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 680 | $200 | $132.9K |
| J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | 1,140 | $100 | $111.3K |
| 66982 | The provider inserts an intraocular lens prosthesis after extracapsular cataract extraction using complex techniques and devices. He may perform this by means of an iris expansion device, providing… | 110 | $810 | $88.6K |
| 65820 | The provider incises the limbus to improve drainage of aqueous humor in the eye. This procedure is typically performed on children, usually to treat congenital glaucoma. | 90 | $890 | $79.7K |
| 67036 | The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana. | 50 | $1,430 | $76K |
Showing 1–10 of 22
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
22 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J1097 | 1 | 10 | 1,360 | $80 | $106.4K |
| J1096 | 4 | 10 | 520 | $100 | $81.6K |
| 66984 | 2 | 420 | 50 | $390 | $74K |
| V2785 | 3 | 10 | 20 | $3,370 | $67.4K |
| 66991 | 2 | 30 | 30 | $1,230 | $55.5K |
| J2403 | 2 | 10 | 82,800 | $1 | $55K |
| 67040 | 4 | 10 | 30 | $1,000 | $38.1K |
| 65820 | 3 | 40 | 30 | $790 | $29.1K |
| 15823 | 14 | 40 | 40 | $530 | $28.6K |
| 67042 | 1 | 30 | 20 | $1,070 | $26.8K |
Showing 1–10 of 22
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 1,250 | $130 | $159.7K |
| C9447 | Injection, phenylephrine and ketorolac, 4 ml vial | 10 | $200 | $2.8K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 290 | $0 | $0 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 50 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Missouri providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Missouri median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 2 | 60 | 80 | $280 | $53.5K |
| C9447 | Injection, phenylephrine and ketorolac, 4 ml vial | 1 | 10 | 10 | $200 | $2.8K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 6 | 30 | 100 | $0 | $0 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 7 | 10 | 50 | $0 | $0 |
Other providers in the same ZIP code as Des Peres Eye Surgery Center, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.